Company profile
Imagin Medical Inc.
OTC: IMEXF · Healthcare · Medical - Devices
Canadian filerHQ Vancouver, BCReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 34
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ Piotroski F, market scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$2.0M
Employees
10
as of 2026-08-31
Market cap
$1.1k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2022
Net income-$2.0M-2.5M CAD2022
Operating income-$2.7M-3.4M CAD2022
Total assets$985.5k1.4M CAD2022
Liabilities$10.7M14.7M CAD2022
Equity-$9.7M-13.3M CAD2022
Revenue trend
FY2017 – FY2022 · USD
FY17
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Imagin Medical Inc.’s revenue?
Imagin Medical Inc. booked $0 in FY2022 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Speakeasy Cannabis Club Ltd.——Biomagnetics Diagnostics Corp.——PhaseRx, Inc.——CVR Medical Corp.——Lynx Global Digital Finance Corporation——Grupo International Inc.——Key facts
CEOE. James Hutchens
SectorHealthcare
IndustryMedical - Devices
HeadquartersVancouver, BC
ExchangeOTC: IMEXF
Employees10
IPO date2009-07-10
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.